Matches in Wikidata for { <http://www.wikidata.org/entity/Q37004430> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q37004430 description "article científic" @default.
- Q37004430 description "article scientifique" @default.
- Q37004430 description "articolo scientifico" @default.
- Q37004430 description "artigo científico" @default.
- Q37004430 description "artículu científicu espublizáu en 1997" @default.
- Q37004430 description "bilimsel makale" @default.
- Q37004430 description "scientific article published on April 1997" @default.
- Q37004430 description "vedecký článok" @default.
- Q37004430 description "vetenskaplig artikel" @default.
- Q37004430 description "videnskabelig artikel" @default.
- Q37004430 description "vědecký článek" @default.
- Q37004430 description "wetenschappelijk artikel" @default.
- Q37004430 description "wissenschaftlicher Artikel" @default.
- Q37004430 description "наукова стаття, опублікована у квітні 1997" @default.
- Q37004430 description "научни чланак" @default.
- Q37004430 description "مقالة علمية نشرت في أبريل 1997" @default.
- Q37004430 name "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 name "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 name "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 type Item @default.
- Q37004430 label "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 label "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 label "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 prefLabel "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 prefLabel "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 prefLabel "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 P1433 Q37004430-03BF6CCD-1BF0-4AF6-985D-25057C288818 @default.
- Q37004430 P1476 Q37004430-A55E1083-C8EF-41A4-96EE-13AFE956BD09 @default.
- Q37004430 P2093 Q37004430-08867869-C3B0-4D2B-A557-3AE3CD87FD81 @default.
- Q37004430 P2093 Q37004430-10C7E68F-63A3-4D62-AAF7-213889A9A508 @default.
- Q37004430 P2888 Q37004430-10CDFF52-6787-4382-BA14-3D3109BB9BB2 @default.
- Q37004430 P304 Q37004430-AA47176A-CD94-4454-AEF0-9EB8D1B6052E @default.
- Q37004430 P31 Q37004430-73261816-3D23-4557-857F-67BE0080DA58 @default.
- Q37004430 P356 Q37004430-72BB1EB4-A4D7-4A51-8E7B-1918F8853ECC @default.
- Q37004430 P433 Q37004430-6BAD080D-8A86-4DEF-8330-ADB406BC0FEE @default.
- Q37004430 P478 Q37004430-6694A481-976D-4B04-994E-957421424388 @default.
- Q37004430 P577 Q37004430-9C787DCF-DADF-41F0-8AA6-849432A00167 @default.
- Q37004430 P6179 Q37004430-93E5EA41-0D4A-4FB7-B1F5-235E91C883FC @default.
- Q37004430 P698 Q37004430-912769F5-C023-49CF-9B1A-535B55C819E0 @default.
- Q37004430 P921 Q37004430-03b52f6b-a1a8-473e-926a-f9d113137878 @default.
- Q37004430 P921 Q37004430-C2061C3C-98D4-4474-8DE1-828C10C6AB7B @default.
- Q37004430 P356 00063030-199707040-00005 @default.
- Q37004430 P698 18020488 @default.
- Q37004430 P1433 Q4914612 @default.
- Q37004430 P1476 "Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma" @default.
- Q37004430 P2093 "Goa KL" @default.
- Q37004430 P2093 "Jeal W" @default.
- Q37004430 P2888 00063030-199707040-00005 @default.
- Q37004430 P304 "285-317" @default.
- Q37004430 P31 Q13442814 @default.
- Q37004430 P356 "10.2165/00063030-199707040-00005" @default.
- Q37004430 P433 "4" @default.
- Q37004430 P478 "7" @default.
- Q37004430 P577 "1997-04-01T00:00:00Z" @default.
- Q37004430 P6179 "1044355095" @default.
- Q37004430 P698 "18020488" @default.
- Q37004430 P921 Q128406 @default.
- Q37004430 P921 Q194908 @default.